Children are the latest test subjects of FluGen’s universal flu vaccine
167480
post-template-default,single,single-post,postid-167480,single-format-standard,bridge-core-1.0.5,tribe-no-js,tribe-bar-is-disabled,ajax_fade,page_not_loaded,,qode_grid_1300,footer_responsive_adv,hide_top_bar_on_mobile_header,qode-content-sidebar-responsive,qode-child-theme-ver-1.0.0,qode-theme-ver-18.1,qode-theme-bridge,qode_header_in_grid,wpb-js-composer js-comp-ver-6.0.2,vc_responsive
 

Children are the latest test subjects of FluGen’s universal flu vaccine

Children are the latest test subjects of FluGen’s universal flu vaccine

An influenza vaccine developed by FluGen, of Madison, is being tested on children and teenagers in a clinical trial that’s being subsidized by a division of the National Institutes of Health.

The test began in August, according to a statement last week by the National Institute of Allergy and Infectious Diseases.

Fifty healthy children between the ages of 9 and 17 will be studied at a vaccine and treatment evaluation unit at Saint Louis University, in St. Louis, Missouri, over the next year.

READ FULL STORY